Información del artículo
Resumen
La trombocitopenia inmunológica engloba una seriede entidades clínicas adquiridas cuya base fisiopatológica es la acción de un autoanticuerpo antiplaquetario.Describimos el caso de una primigesta con un cuadrode trombocitopenia inmunológica idiopática diagnosticada en la infancia, en situación estable, que se agravó durante la gestación cursando con trombopeniagrave, sintomatología hemorrágica leve y un cuadrode hipertensión inducida por el embarazo, que se complicó con un crecimiento intrauterino retardado.
Summary
Immunological thrombocytopoenia covers a series of acquired clinical entities whose pathological base is an antibody with antiplatelet action. We describe the case of a primigravida with stable idiopathic immunological thrombocytopoenia diagnosed in childhood which became worse during pregnancy, with severe thrombocytopoenia, haemorrhage symptoms, and hypertension of pregnancy complicated by intrauterine growth retardation.
El Texto completo está disponible en PDF
Bibliografía
[1.]
R.F. Burrows.
Platelet disorders in pregnancy.
Curr Opin Obstet Gynecol, 13 (2001), pp. 115-119
[2.]
R. Salim, Z. Nachum, E. Shalev.
Immune thrombocytopenic purpura in pregnancy.
Harefuah, 140 (2001), pp. 236-242
[3.]
M. Greaves.
Autoimmune thrombophilic syndromes.
Hae-matologica, 84(Suppl EHA 4 (1999), pp. 32-35
[4.]
D.M. Paternoster, C. Santarossa, G. Manfreda.
Idiopathic thrombocytopenic purpura and pregnancy.
Int J Gynaecol Obstet, 65 (1999), pp. 207-208
[5.]
R.S. Egerman, B.M. Sibai.
Imitators of preeclampsia and eclampsia.
Clin Obstet Gynecol, 42 (1999), pp. 551-562
[6.]
J. Gilabert, M. Galbis, J. Aznar, J. Monleón.
Alteraciones de la hemostasia obstetricia.
[7.]
G.C. Christiaens.
Immune thrombocytopenic purpura in pregnancy.
Baillieres Clin Haematol, 11 (1998), pp. 373-380
[8.]
L. Porcelijn, dem Borne AE. Von.
Immune-mediated thrombocytopenias: basic and immunological aspects.
Baillieres Clin Haematol, 11 (1998), pp. 331-341
[9.]
J. Bonnar, W.E. Hathaway.
Hemostatic disorders of the pregnant women and newborn infant.
[10.]
J.S. Wiley.
Idiopathic thrombocytopenic purpura in adults.
Med J Aust, 170 (1999), pp. 196-197
[11.]
F. Moccia.
Two cases of autoimmune thrombocytopenic purpura associated with antiphospholipid antibodies.
Ann Ital Med Int, 14 (1999), pp. 114-117
[12.]
J. Rajantie, E. Juvonen.
Diagnostics and treatment of throm-bocytopenia.
Duodecim, 114 (1998), pp. 1203-1209
[13.]
M. De Spirlet, F. Goffinet, H.J. Philippe, M. Bailly, S. Couderc, I. Nisand.
Prenatal diagnosis of a subdural hematoma associated with reverse flow in the middle cerebral artery: case report and literature review.
Ultrasound Obstet Gynecol, 16 (2000), pp. 72-76
[14.]
K.K. Gill, J.G. Kelton.
Management of idiopathic thrombocyto-penic purpura in pregnancy.
Semin Hematol, 37 (2000), pp. 275-289
[15.]
D.W. Branch, T.F. Porter, M.J. Paidas, M.A. Belfort, B. Gonik.
Obstetric uses of intravenous immunoglobulin: successes, failures, and promises.
J Allergy Clin Immunol, 108(4 Suppl (2001), pp. S133-8
[16.]
S.G. Sandler.
Treating immune thrombocytopenic purpura and preventing Rh alloimmunization using intravenous rho (D) immune globulin.
Transfus Med Rev, 15 (2001), pp. 67-76
[17.]
A.L. Clark.
Clinical uses of intravenous immunoglobulin in pregnancy.
Clin Obstet Gynecol, 42 (1999), pp. 368-380
[18.]
V. Blanchette, M. Carcao.
Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura.
Transfus Sci, 19 (1998), pp. 279-288
[19.]
S. Shimano, K. Murayama, A. Yokohama, N. Murata, J. Tsuchi-ya.
Marked thrombocytopenia after high-dose intravenous gamma globulin in a pregnant woman with idiopathic thrombocytopenic purpura.
Rinsho Ketsueki, 40 (1999), pp. 318-323
[20.]
R. Lush, H. Iland, B. Peat, G. Young.
Successful use of dapso-ne in refractory pregnancy-associated idiopathic throm-bocytopenic purpura.
Aust N Z J Med, 30 (2000), pp. 105-107
[21.]
T.Y. Euliano.
Cesarean section combined with splenectomy in a parturient with immune thrombocytopenic purpura.
J Clin Anesth, 13 (2001), pp. 313-318
[22.]
J.B. Bussel.
Splenectomy-sparing strategies for the treatment and long-term maintenance of chronic idiopathic (immune) thrombocytopenic purpura.
Semin Hematol, 37 (Suppl 1 (2000), pp. 1-4
[23.]
P. Gottlieb, O. Axelsson, O. Bakos, J. Rastad.
Splenectomy during pregnancy: an option in the treatment of autoimmune throm-bocytopenic purpura.
Br J Obstet Gynaecol, 106 (1999), pp. 373-375
[24.]
R. Burrows.
Splenectomy during pregnancy: an option in treatment of autoimmune thrombocytopenic purpura.
Br J Obstet Gynaecol, 106 (1999), pp. 1330-1331
[25.]
F. Sendag, M. Kazandi, M.C. Terek.
Splenectomy combined with cesarean section in a patient with severe immunological thrombocytopenic purpura refractory to medical therapy.
J Obstet Gynaecol Res, 27 (2001), pp. 85-88
[26.]
T. Mori, F. Karasawa, I. Fukuda, M. Tokunaga, M. Shizukuishi, Y. Kawatani, et al.
Anesthetic management of cesarean section for a patient with idiopathic thrombocytopenic purpura..
Masui, 49 (2000), pp. 903-905
[27.]
B.V. Anglin, C. Rutherford, R. Ramus, M. Lieser, D.B. Jones.
Immune thrombocytopenic purpura during pregnancy: lapa-roscopic treatment.
JSLS, 5 (2001), pp. 63-67
[28.]
K. Iwase, J. Higaki, H.E. Yoon, S. Mikata, Y. Tanaka, T. Taka-hashi, et al.
Hand-assisted laparoscopic splenectomy for idiopathic thrombocytopenic purpura during pregnancy.
Surg Laparosc Endosc Percutan Tech, 11 (2001), pp. 53-56
[29.]
W. Szymanski, J. Sarap, A. Kujawa, M. Pasinska.
The course of pregnancy and delivery among women with thrombocytopenia.
Ginekol Pol, 69 (1998), pp. 1003-1006
[30.]
J. Gilabert, Y. Mira, F. Ridocci, I. Lozano, J. Aznar.
Valora-ción plaquetar fetal intraparto. ¿Es útil en el manejo de la trombopenia inmune neonatal?.
Rev Diag Biol, 36 (1987), pp. 247-250
[31.]
Forestier F, Daffos F, Kaplan C, Sole Y. The development of the coagulation in human fetus and the prenatal diagnosis and management of bleding disorders with fetal blood sampling. En: Haemostasis and thrombosis in obstetrics and gynecology. Greer
[32.]
D. Peleg, S.K. Hunter.
Perinatal management of women with immune thrombocytopenic purpura: survey of United States perinatologists.
Am J Obstet Gynecol, 180 (1999), pp. 645-649
[33.]
T. Razafintsalama, J. Coiffic, O. Godin, L. Lassel, O. Chevrant-Bre-ton, P. Poulain.
Percutaneous umbilical blood sampling in pregnant women with thrombocytopenia. Apropos of 35 cases.
J Gynecol Obstet Biol Reprod (Paris, 29 (2000), pp. 176-184
[34.]
N. Vianelli, S. Baravelli, V. Milano, N. Rizzo, L. Catani, S. Tura.
Percutaneous umbilical blood sampling in the management of immune thrombocytopenic purpura during pregnancy.
Haematologica, 83 (1998), pp. 1127-1128
[35.]
G. Wegnelius, G. Elinder.
Idiopathic thrombocytopenia during pregnancy. The risk in connection with umbilical blood sampling is probably greater than the benefit.
Lakartidnin-gen, 98 (2001), pp. 3403-3409
[36.]
A. Widmer, H. Bruhwiler, M. Krause, K.P. Luscher.
Severe autoimmune thrombocytopenia in pregnancy.
Z Geburtshilfe Neonatol, 203 (1999), pp. 258-260
[37.]
C. Kaplan, F. Dalfos, F. Forestier, T. Tertian, N. Catherine, C. Pons J, et al.
Fetal platelet counts in thrombocytopenic pregnancy.
Lancet, 336 (1990), pp. 979-982
[38.]
A. Faridi, W. Rath.
Differential diagnosis of thrombocytope-nia in pregnancy.
Zentralbl Gynakol, 123 (2001), pp. 80-90
[39.]
M. Tomicic, M. Dekovic, J. Jaksic, E. Stoini, V. Drazic, B. Gra-hovac, et al.
Neonatal alloimmune thrombocytopenic pur-pura caused by anti-HPA-1a alloantibodies.
Case report Lijec Vjesn, 123 (2001), pp. 70-73
[40.]
S. Sainio, K. Javela, R. Kekomaki, K. Teramo.
Thrombopoietin levels in cord blood plasma and amniotic fluid in fetuses with alloimmune thrombocytopenia and healthy controls.
Br J Haematol, 109 (2000), pp. 330-335
[41.]
J. Bussel, C. Kaplan.
The fetal and neonatal consequences of maternal alloimmune thrombocytopenia.
Baillieres Clin Ha-ematol, 11 (1998), pp. 391-408
[42.]
C. Kaplan.
Immune thrombocytopenia in the foetus and the newborn: diagnosis and therapy.
Transfus Clin Biol, 8 (2001), pp. 311-314
[43.]
H. Yamada, E.H. Kato, G. Kobashi, T. Kishida, Y. Ebina, M. Ka-neuchi, et al.
Passive immune thrombocytopenia in neonates of mothers with idiopathic thrombocytopenic purpura: incidence and risk factors.
Semin Thromb Hemost, 25 (1999), pp. 491-496
[44.]
H. Kroll, G. Bein.
Neonatal autoimmune thrombocytopenia.
Dtsch Med Wochenschr, 124 (1999), pp. 1435-1436
[45.]
T.B. Song, J.Y. Lee, Y.H. Kim, Y.Y. Choi.
Low neonatal risk of thrombocytopenia in pregnancy associated with immune thrombocytopenic purpura.
Fetal Diagn Ther, 14 (1999), pp. 216-219
[46.]
H.A. Baptista, M.D. Mejía, V.M. Vidal, F. Rosenfeld, R. Hernán-dez, R. Ángeles.
Neonatal consequences of maternal au-toimmune thrombocytopenic purpura.
Sangre (Barc, 44 (1999), pp. 24-29
Copyright © 2002. Elsevier España, S.L.. Todos los derechos reservados
